US Patent Issued to Hyloris Developments on Jan. 13 for "Intravenous dofetilide to convert atrial fibrillation/flutter" (Illinois Inventor)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,357, issued on Jan. 13, was assigned to Hyloris Developments SA (Liege, Belgium).

"Intravenous dofetilide to convert atrial fibrillation/flutter" was invented by John Somberg (Lake Forest, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention involves a novel method of converting atrial fibrillation (AF) or atrial flutter (AFL) in a patient presenting with highly symptomatic AF or AFL by administering at least a loading dose of dofetilide intravenously, or if that fails cardioversion and a maintenance infusion followed by a switch to chronic oral dosing."

The patent was filed on Feb. 28, 2023, under Application No. 18/176,017.

*For fur...